Overview
Pediatric cancer care comprises a rapidly evolving field across solid and hematologic malignancies. Advances in treatment strategies including chemotherapeutic, immunotherapeutic, and targeted agents have changed the landscape and expanded the arsenal of available agents for treating pediatric patients. Novel techniques to detect and characterize tumors have further created new opportunities to improve outcomes in pediatric and adolescent/young adult (AYA) patients with cancer.
This virtual educational congress will feature expert updates and interpretation of clinical trial data across a variety of tumor subspecialties pertinent to pediatric cancer. Attendees will have the opportunity to learn about emerging therapeutics, novel approaches with currently available agents, ongoing clinical trials, and other clinically relevant developments in pediatric oncology care.
Learning Objectives
- Evaluate recent clinical trial data for targeted therapies and immunotherapies across pediatric malignancies
- Integrate recently approved agents into risk- and response-adapted treatment planning for pediatric malignancies
- Implement evidence-based approaches for recognition and management of treatment- and immune-related complications across pediatric malignancies
Target Audience
This educational activity is directed toward pediatric oncologists, hematologists, hematologist/oncologists, nurses, nurse practitioners, patient advocates, and pharmacists involved in the treatment/management of pediatric oncology.
Jacqueline M. Kraveka, DO
Professor of Pediatrics
Institutional COG Principal Investigator
Institutional BCC Principal Investigator
MUSC Shawn Jenkins Children’s Hospital
Medical University of South Carolina
Hollings Cancer Center - A National Cancer Institute Designated Cancer Center
Division of Pediatric Hematology-Oncology
Charleston, SC
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 7.0 Contact Hours.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 7.0 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.
There are several opportunities (both continuing education [CE] and non-CE) available for companies, associations, and societies interested in supporting this year's conference.
For Continuing Education, Associations, and Societies
Please email grants@gotoper.com for information about this upcoming conference.
Exhibitors
Exhibit at this year’s meeting and increase your visibility. Our custom sponsorship packages provide outstanding recognition and increased awareness of your company’s products and services. Don’t miss this opportunity to reach this important target audience.
For additional details, contact:
Elisha Ball | Associate Director of Sales
OncLive® Events & Intellisphere Oncology Specialty Group
Cell: (610) 563-1620
Email: egarcia@onclive.com
Maddison Martini | National Accounts Associate
OncLive® Events & Intellisphere Oncology Specialty Group
Cell: (609) 947-8377
Email: mmartini@mjhlifesciences.com
OncLive® Events & Intellisphere Oncology Specialty Group
259 Prospect Plains Rd, Building H, Monroe, NJ 08831
Web: http://www.onclive.com
Advisory Board or Ancillary Meeting Definition
Any meeting whose invited participants are professional attendees of the Conference, such as doctors and physicians will be considered an Advisory Board (Ad Board) or Ancillary Meeting. This includes activities such as round-table discussions, investigator meetings, social gatherings and meet the specialist‐type meetings.
A fee is applicable for hosting these meetings, with the amount being dependent on the type and size of your meeting.
Blackout Times
There are many programs being scheduled throughout our conferences. With that, the black out hours across our meeting are as follows:
- One day prior to the conferences
- The duration of the conference
- One day post conference
To review your meeting request, please contact Elisha Ball or Maddison Martini.
A cancellation fee of 25% will be assessed on refunds requested 90 days before the start date, a 50% fee on refunds requested 60 days before the start date, and a 75% fee on refunds requested 30 days before the start date. No refunds will be made after 30 days before the start date. There is no charge for substitution. Substitutions can only be applied to the same conference and only two substitutions will be honored.
In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.
PER® reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting continuing education materials.